ARTICLE | Management Tracks
Everest names new CEO; plus Merck, Gilead, Turning Point, Adaptimmune, AskBio and more
February 22, 2020 1:00 AM UTC
Everest Medicines Ltd. hired Kerry Blanchard as CEO. Blanchard, who will also join the company’s board, succeeds interim CEO Sean Cao. Blanchard was an operating partner at Everest’s founding investor CBC Group and previously served as CSO of Innovent Biologics Inc. (HKEX:1801). Cao, who is also a managing director at CBC Group, will continue as a senior adviser to the executive leadership team.
Jim Scholefield has stepped down as chief information and digital officer at Merck & Co. Inc. (NYSE:MRK) to take on the same position at Marriott International Inc. (NASDAQ: MAR)...